AMZN
Amazon.com, Inc.
AMZN has the edge over SBH overall, supported by stronger valuation and stronger modeled upside.
SBH
Sally Beauty Holdings, Inc.
SBH's outlook is improving, though it still trails on the overall score.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
SBH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
SBH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over SBH in the historical PE scenario, which offers more potential upside but is not a forecast.
SBH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.1x | $12.33 | -33% |
| Fair | 7.9x | $15.93 | -13% |
| Forward | 8.2x | $18.41 | — |
| Current | 9.1x | $18.41 | — |
| Expensive | 9.8x | $19.70 | +7% |
Historical ranges are pointers, not guarantees.
SBH's PE is in its expensive range at 9.1x. If earnings grow as analysts expect, today's price would be 8.2x next year's earnings, in its fair range.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
SBH Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Limited | |
| High |
Analysts expect SBH's earnings to grow and its profitability to improve, with its revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over SBH on earnings, with stronger typical year-over-year growth.
SBH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.26 | +12% |
| Q3 2026 | $2.02 | +6.9% |
| Q2 2026 | $1.92 | +3.8% |
| Q1 2026 | $1.81 | +2.3% |
| Q4 2025 | $1.76 | +6% |
| Q3 2025 | $1.89 | +32% |
| Q2 2025 | $1.85 | +34% |
| Q1 2025 | $1.77 | +20% |
| Q4 2024 | $1.66 | +5.1% |
SBH's earnings per share have climbed steadily: $2.02 over the past year, up 6.9% from the year before, and higher year over year for eight quarters in a row.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over SBH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over SBH on profitability, with a higher operating margin.
SBH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $952.5M | +0.6% |
| Q2 2026 | $935.5M | +0.2% |
| Q1 2026 | $903.4M | +2.3% |
| Q4 2025 | $943.2M | +0.6% |
| Q3 2025 | $947.1M | +1.3% |
| Q2 2025 | $933.3M | -1% |
| Q1 2025 | $883.1M | -2.8% |
| Q4 2024 | $937.9M | +0.7% |
SBH's revenue has held roughly level: $953M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.7% | +1.2 points |
| Q2 2026 | 9.2% | +0.9 points |
| Q1 2026 | 8% | +0.1 points |
| Q4 2025 | 8.1% | -2.6 points |
| Q3 2025 | 8.4% | -0.4 points |
| Q2 2025 | 8.4% | +0.8 points |
| Q1 2025 | 7.9% | +1.3 points |
| Q4 2024 | 11% | +3.3 points |
SBH's operating margin was 9.7% last quarter, up 1.2 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
SBH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $46.9M | -40% |
| Q2 2026 | $61.6M | +25% |
| Q1 2026 | $44.1M | +37% |
| Q4 2025 | $57.5M | +329% |
| Q3 2025 | $78M | +6.4% |
| Q2 2025 | $49.1M | +71% |
| Q1 2025 | $32.2M | +41% |
| Q4 2024 | $13.4M | -35% |
SBH has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
SBH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +902K shares |
| 1 year | -4.8% | -5M shares |
| 3 years | -9.6% | -10.5M shares |
| 5 years | -13% | -15.4M shares |
| Available history | -16% | -18.3M shares |
SBH has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $41.9M |
| Q2 2026 | $25.6M |
| Q1 2026 | $25.6M |
| Q4 2025 | $20.8M |
| Q3 2025 | $20.7M |
| Q2 2025 | $13.2M |
| Q1 2025 | $10.2M |
| Q4 2024 | $9.9M |
SBH spent $114M buying back its own shares over the past year, up 111% from the year before.
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over SBH on leverage, with a lower net debt burden relative to earnings.
SBH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.5x | Healthy |
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 1.7x | Healthy |
| Q4 2025 | 1.7x | Healthy |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.8x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 2.0x | Healthy |
SBH's net debt is about 1.5 years of its operating earnings (EBITDA), down from 1.7 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
SBH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 65.5 | Neutral |
| Stochastic | 72.0 | Neutral |
SBH's weekly RSI is 65 (neutral) and its Stochastic is 72 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
SBH PE vs Consumer Cyclical Sector
| Metric | SBH | Sector median | Relative |
|---|---|---|---|
| PE | 9.1x | 18x | 49% below |
| PE % | 76 | 47 | 29 pts above |
SBH has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN is in an uptrend: it's above all five of its weekly moving averages, and 40% above its 200-week average.
SBH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.3 | 6.5% above |
| 20 week MA | $16.4 | 13% above |
| 50 week MA | $15.2 | 21% above |
| 100 week MA | $13.2 | 39% above |
| 200 week MA | $12.6 | 46% above |
SBH is in an uptrend: it's above all five of its weekly moving averages, and 46% above its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
SBH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $18.1 | $12.7 | -30% |
| 2021 | $12.7 | $18.6 | +47% |
| 2022 | $18.6 | $12.5 | -33% |
| 2023 | $12.5 | $13.3 | +6.4% |
| 2024 | $13.3 | $10.8 | -18% |
| 2025 | $10.8 | $15.0 | +38% |
| 2026 YTD | $15.0 | $18.4 | +23% |
SBH has the edge over AMZN on returns for 2026, with the stronger performance.